Literature DB >> 640255

Psychomotor development of infants and children after profound hypothermia during surgery for congenital heart disease.

K Haka-Ikse, M J Blackwood, D J Steward.   

Abstract

We assessed neurological status and cognitive, verbal, social and motor skills of 17 children who had undergone cardiac surgery under profound hypothermia, and of seven siblings (controls). None of the subjects had significant neurological impairment. The mean development quotient (DQ) for the patients was 92.5 (in the low-average range) and for the controls was 103 (average). The DQ of one patient (71) was below the normal range. Development of the patients was comparable with that reported by other authors for children with cyanotic congenital heart-disease who have not undergone cardiac surgery. It correlated with the type of congenital heart-disease but not with the duration of hypoxic arrest. It is concluded that profound hypothermia can be used safely during the correction of cardiac defects in infants, without fear of retarding psychomotor development.

Entities:  

Mesh:

Year:  1978        PMID: 640255     DOI: 10.1111/j.1469-8749.1978.tb15181.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  4 in total

1.  Cyanotic congenital heart disease.

Authors:  G A Trusler
Journal:  Tex Heart Inst J       Date:  1982-12

2.  Quality of life and perceived health status in surviving adults with univentricular heart.

Authors:  Z Saliba; G Butera; D Bonnet; P Bonhoeffer; E Villain; J Kachaner; D Sidi; L Iserin
Journal:  Heart       Date:  2001-07       Impact factor: 5.994

3.  Near-drowning in cold fresh water: current treatment regimen.

Authors:  A W Conn; J F Edmonds; G A Barker
Journal:  Can Anaesth Soc J       Date:  1978-07

4.  Intellectual performance in children after circulatory arrest with profound hypothermia in infancy.

Authors:  D F Dickinson; J E Sambrooks
Journal:  Arch Dis Child       Date:  1979-01       Impact factor: 3.791

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.